Zepbound cost at a glance (2026)
| Path | Cost / mo | Best for |
|---|---|---|
| Compounded tirzepatide | $179 | Uninsured cash-pay (cheapest) |
| Zepbound Savings Card | $25 | Commercial insurance + covering plan |
| LillyDirect (vials) | $399 | Cash-pay, want brand-Lilly product |
| GoodRx + retail | $900-1,000 | Modest savings on retail |
| Retail cash-pay (pens) | $1,059 | Almost never the right choice |
Path 1: Zepbound Savings Card — $25/month with commercial insurance
The Zepbound Savings Card is Lilly's manufacturer copay assistance program. Eligible patients with commercial insurance that covers Zepbound pay as low as $25 per month for a 28-day supply (with monthly and annual savings caps). This is the cheapest path for insured patients whose plan includes Zepbound on formulary.
Eligibility:
- Commercial (private) insurance that covers Zepbound
- US resident with valid prescription
- BMI ≥30, OR BMI ≥27 with at least one weight-related comorbidity
- NOT eligible: Medicare, Medicaid, VA, Tricare, or any other federal/state insurance enrollee
Apply at zepbound.lilly.com. The card is presented at the pharmacy, which applies the discount automatically when the prescription is filled.
Path 2: LillyDirect — $399/month for cash-pay vials
LillyDirect is Eli Lilly's direct-to-patient pharmacy, launched 2024 specifically to give cash-pay patients a more affordable Zepbound path. The product sold through LillyDirect is the single-dose vial format (rather than the all-in-one prefilled pen), which dramatically reduces the device cost while keeping the medication identical.
How it works:
- Visit lillydirect.com to start the intake
- Connects you with a partner telehealth provider (FORM Health, 9amHealth, etc.) for the prescription
- Vials ship from LillyDirect's pharmacy partner
- $399 covers the medication; you handle injection supplies (syringes from Amazon or pharmacy)
The catch: LillyDirect prescribes through partner telehealth networks, so the consult and ongoing monitoring fees are separate from the $399 medication cost. Total all-in monthly cost is typically $450-550 depending on which telehealth partner you go through.
Path 3: Compounded tirzepatide — $179/month, the cheapest path
Compounded tirzepatide is the same active ingredient as Zepbound, prepared by a state- licensed 503A pharmacy under FDA-permitted conditions. Programs like Direct Meds, Henry Meds (compounded plan), and others offer compounded tirzepatide at $179-249/month for cash-pay patients without insurance.
Important caveats:
- Compounded tirzepatide is NOT FDA-approved as a standalone product
- It's legal when prepared by a registered 503A or 503B pharmacy under specific FDA conditions (most commonly while the brand is on the FDA shortage list)
- Quality varies by pharmacy — verify state board of pharmacy licensure before ordering
- FDA shortage status for tirzepatide ended early 2025; ongoing compounding requires careful pharmacy compliance
Path 4: GoodRx + retail pharmacy — modest savings
GoodRx coupons exist for Zepbound at most major retail pharmacies (CVS, Walgreens, Walmart, Costco). Discounts run 5-15% off retail, so cash-pay falls from $1,059 to roughly $900-1,000/month with a GoodRx code applied at the pharmacy counter.
For most patients, GoodRx is the wrong path for Zepbound — the savings are too small relative to LillyDirect ($399), the manufacturer savings card ($25 with insurance), or compounded tirzepatide ($179). GoodRx makes sense only when none of the cheaper paths are available.
Path 5: Retail cash-pay (pens) — almost never the right choice
Brand-name Zepbound prefilled pens at retail without insurance: $1,059/month. This is Eli Lilly's wholesale list price translated through the retail pharmacy markup. For uninsured cash-pay patients, this path is dominated by every other option in this guide. The only justification is patient preference for the prefilled pen format AND unavailability of LillyDirect's vial program — a narrow case.
Path 6: Patient Assistance Programs (PAPs) — uninsured low-income
Lilly Cares Foundation provides free Zepbound to income-qualified uninsured patients (typically household income below 400% of federal poverty level). Application process takes 4-8 weeks; once approved, medication ships quarterly through participating prescribers.
For most uninsured patients, LillyDirect ($399) is faster than navigating PAP eligibility. PAPs remain the right path for patients who genuinely cannot afford even the LillyDirect rate.
What about insurance prior authorization?
Most commercial insurance plans require prior authorization (PA) for Zepbound. The PA process typically requires:
- Documented BMI ≥30 (or ≥27 with comorbidity) at the time of prescribing
- Failed attempts at lifestyle intervention (most plans accept self-reported)
- Some plans require step-therapy through Wegovy or Saxenda first
- Some plans require periodic weight-loss documentation to maintain coverage
Telehealth providers with dedicated PA teams (Henry Meds, Mochi, Found, Hims) are the fastest path through the PA process. Independent of any insurance pathway, the medication cost under a savings card is $25/month for eligible patients once PA is approved.
FAQ
How much does Zepbound cost in 2026?
Zepbound's retail cash-pay price is approximately $1,059 for a 28-day supply. With the Zepbound Savings Card (commercial insurance required), eligible patients pay as low as $25/month. LillyDirect, Lilly's direct-to-patient pharmacy, sells the lower-cost vial presentation at $399/month for cash-pay patients without insurance coverage.
What's the cheapest way to get Zepbound without insurance?
LillyDirect at $399/month is the cheapest brand-name path for cash-pay patients. For patients prioritizing absolute lowest cost, compounded tirzepatide from a state-licensed 503A pharmacy (the same active ingredient as Zepbound) starts at $179/month through programs like Direct Meds. Compounded tirzepatide is legal when prepared by a registered pharmacy under specific FDA conditions; verify the pharmacy's state board licensure before ordering.
Is the Zepbound coupon really $25 per month?
Yes, for eligible patients. The Zepbound Savings Card drops out-of-pocket cost to $25/month for commercially insured patients with coverage that includes Zepbound. Federal-plan enrollees (Medicare, Medicaid, VA, Tricare) cannot use the savings card by federal anti-kickback law. For patients without commercial insurance or with non-covering insurance, the savings card doesn't apply.
What insurance covers Zepbound?
As of 2026, most commercial insurance plans cover Zepbound for patients meeting FDA criteria (BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity like hypertension, sleep apnea, or dyslipidemia). Many plans require prior authorization plus step-therapy through Wegovy or Saxenda first. Medicare Part D does not cover Zepbound for weight loss (per federal rules excluding obesity drugs), but Medicare DOES cover Zepbound for the moderate-to-severe sleep apnea indication added in late 2024.
How does Zepbound cost compare to Wegovy?
Zepbound retail cash-pay ($1,059) is comparable to Wegovy retail ($1,349). Both have manufacturer savings cards that drop commercial-insurance copay to $0-25/month. LillyDirect ($399 for Zepbound vials) is currently a cheaper cash-pay option than NovoCare ($499 for Wegovy). For patients without insurance, Zepbound is the cheaper brand-name path in 2026.
Can I use a GoodRx coupon for Zepbound?
GoodRx coupons exist for Zepbound but typically only drop the price by 5-15% off retail (so $900-1,000/month after coupon vs $1,059 retail). The savings are real but modest compared to LillyDirect ($399), the manufacturer savings card ($25 with eligibility), or compounded tirzepatide ($179). For most patients, GoodRx is the wrong path for Zepbound specifically.
What's the cost difference between Zepbound vials and pens?
Zepbound is sold in two formats: prefilled pens (the original presentation) and single-dose vials (introduced 2024). Vials are dramatically cheaper at the LillyDirect cash-pay rate ($399/month) because they require self-injection with a separate syringe rather than the all-in-one pen device. The medication itself (tirzepatide) is identical. For cash-pay patients, the vial path saves roughly $660/month over pen retail.
Are there Patient Assistance Programs for Zepbound?
Yes. Lilly Cares Foundation provides free Zepbound to income-qualified uninsured patients (typically household income below 400% of federal poverty level). Application process takes 4-8 weeks; once approved, medication ships quarterly through participating prescribers. Most patients find LillyDirect cash-pay ($399) faster than navigating PAP eligibility, but PAPs remain the right path for patients who genuinely cannot afford even the LillyDirect rate.
Bottom line on Zepbound cost in 2026
For commercially insured patients with covering plans: $25/month via the savings card is the cheapest legitimate path. For cash-pay patients: $179-249/month for compounded tirzepatide is the cheapest, with $399/month at LillyDirect as the brand-Lilly alternative. Retail cash-pay at $1,059/month is rarely justified.
Find my best Zepbound path →